PL2134743T3 - Ulepszone szczepionki przeciw Bordetella pertussis oparte na mutantach glikozylo-transferazy LPS - Google Patents

Ulepszone szczepionki przeciw Bordetella pertussis oparte na mutantach glikozylo-transferazy LPS

Info

Publication number: PL2134743T3
Authority: PL; Poland
Prior art keywords: improved; bordetella pertussis; vaccines based; pertussis vaccines; lps
Prior art date: 2007-03-26

Application number

PL08723920T

Other languages

English (en)

Inventor

Jeroen Johannes Gerardus Geurtsen

Johannes Petrus Maria Tommassen

Der Ley Peter André Van

Original Assignee

De Staat Der Nederlanden Vert Door De Mini Van Vws

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-26

Filing date

2008-03-25

Publication date

2013-01-31

2008-03-25 Application filed by De Staat Der Nederlanden Vert Door De Mini Van Vws filed Critical De Staat Der Nederlanden Vert Door De Mini Van Vws

2013-01-31 Publication of PL2134743T3 publication Critical patent/PL2134743T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Oncology (AREA)
Physics & Mathematics (AREA)
Pulmonology (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL08723920T 2007-03-26 2008-03-25 Ulepszone szczepionki przeciw Bordetella pertussis oparte na mutantach glikozylo-transferazy LPS PL2134743T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP07104885		2007-03-26
PCT/NL2008/050169 WO2008118015A2 (en)	2007-03-26	2008-03-25	Improved vaccines against bordetella pertussis based on lps glycosyltransferase mutants
EP08723920A EP2134743B1 (en)	2007-03-26	2008-03-25	Improved vaccines against bordetella pertussis based on lps glycosyltransferase mutants

Publications (1)

Publication Number	Publication Date
PL2134743T3 true PL2134743T3 (pl)	2013-01-31

Family

ID=38134330

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08723920T PL2134743T3 (pl)	2007-03-26	2008-03-25	Ulepszone szczepionki przeciw Bordetella pertussis oparte na mutantach glikozylo-transferazy LPS

Country Status (17)

Country	Link
US (1)	US9296995B2 (pl)
EP (1)	EP2134743B1 (pl)
JP (1)	JP5683260B2 (pl)
KR (1)	KR101667551B1 (pl)
CN (1)	CN101801997B (pl)
AU (1)	AU2008230238B2 (pl)
BR (1)	BRPI0809321A2 (pl)
CA (1)	CA2681924C (pl)
ES (1)	ES2393682T3 (pl)
IL (1)	IL201241A (pl)
MX (1)	MX2009010347A (pl)
NZ (1)	NZ579940A (pl)
PL (1)	PL2134743T3 (pl)
PT (1)	PT2134743E (pl)
RU (1)	RU2542667C2 (pl)
SI (1)	SI2134743T1 (pl)
WO (1)	WO2008118015A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11078257B2 (en)	2016-07-29	2021-08-03	The Regents Of The University Of Michigan	Recombinant gram negative bacteria and methods of generating and utilizing same
CA3055757A1 (en) *	2017-03-13	2018-09-20	De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport	Bordetella vaccines comprising lps with reduced reactogenicity
US10398094B2 (en) *	2017-05-16	2019-09-03	Martin W. Taylor	Impermeable sectional apparatus for soil moisture retention
CN110373438B (zh) *	2019-07-31	2021-05-04	江南大学	一种提高γ-氨基丁酸产量的方法
CN117947054B (zh) *	2024-03-25	2024-06-21	上海羽冠生物技术有限公司	一种百日咳鲍特菌无缝基因编辑的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2305799T3 (en) *	1998-02-27	2016-07-25	Novozymes As	Maltogenic alpha-amylase variants
DK1127137T4 (da) *	1998-11-03	2014-02-10	Nederlanden Staat	LPS med reduceret toksicitet fra genetisk modificerede gram-negative bakterier
US20040029129A1 (en) *	2001-10-25	2004-02-12	Liangsu Wang	Identification of essential genes in microorganisms
CN101203605B (zh) *	2004-12-17	2016-01-27	由卫生福利和体育大臣代表的荷兰王国	革兰氏阴性菌的lps的脱酰基化

2008
- 2008-03-25 CA CA2681924A patent/CA2681924C/en not_active Expired - Fee Related
- 2008-03-25 PL PL08723920T patent/PL2134743T3/pl unknown
- 2008-03-25 KR KR1020097022125A patent/KR101667551B1/ko not_active Expired - Fee Related
- 2008-03-25 RU RU2009139262/10A patent/RU2542667C2/ru not_active IP Right Cessation
- 2008-03-25 JP JP2010500860A patent/JP5683260B2/ja not_active Expired - Fee Related
- 2008-03-25 NZ NZ579940A patent/NZ579940A/en not_active IP Right Cessation
- 2008-03-25 AU AU2008230238A patent/AU2008230238B2/en not_active Ceased
- 2008-03-25 US US12/593,346 patent/US9296995B2/en not_active Expired - Fee Related
- 2008-03-25 BR BRPI0809321-0A patent/BRPI0809321A2/pt not_active Application Discontinuation
- 2008-03-25 SI SI200830829T patent/SI2134743T1/sl unknown
- 2008-03-25 MX MX2009010347A patent/MX2009010347A/es active IP Right Grant
- 2008-03-25 PT PT87239208T patent/PT2134743E/pt unknown
- 2008-03-25 WO PCT/NL2008/050169 patent/WO2008118015A2/en not_active Ceased
- 2008-03-25 ES ES08723920T patent/ES2393682T3/es active Active
- 2008-03-25 EP EP08723920A patent/EP2134743B1/en not_active Not-in-force
- 2008-03-25 CN CN200880017600.1A patent/CN101801997B/zh not_active Expired - Fee Related
2009
- 2009-09-29 IL IL201241A patent/IL201241A/en active IP Right Grant

Also Published As

Publication number	Publication date
CA2681924C (en)	2019-12-31
EP2134743A2 (en)	2009-12-23
IL201241A0 (en)	2010-05-31
US9296995B2 (en)	2016-03-29
BRPI0809321A2 (pt)	2014-09-23
JP2010522557A (ja)	2010-07-08
ES2393682T3 (es)	2012-12-27
MX2009010347A (es)	2009-12-10
KR101667551B1 (ko)	2016-10-19
WO2008118015A3 (en)	2009-06-25
NZ579940A (en)	2012-03-30
AU2008230238A1 (en)	2008-10-02
CN101801997A (zh)	2010-08-11
PT2134743E (pt)	2012-12-21
KR20100015812A (ko)	2010-02-12
AU2008230238B2 (en)	2013-06-06
WO2008118015A2 (en)	2008-10-02
CA2681924A1 (en)	2008-10-02
EP2134743B1 (en)	2012-09-05
IL201241A (en)	2015-02-26
CN101801997B (zh)	2016-06-01
SI2134743T1 (sl)	2013-01-31
RU2009139262A (ru)	2011-05-10
JP5683260B2 (ja)	2015-03-11
RU2542667C2 (ru)	2015-02-20
US20100291153A1 (en)	2010-11-18

Publication	Publication Date	Title
DE602007004271D1 (de)	2010-03-04	Zwischenwirbelabstandsstück
PL2351578T3 (pl)	2017-07-31	Sposób wytwarzania szczepionek
ATE462445T1 (de)	2010-04-15	Prrs-impfstoffe
BRPI0814594A2 (pt)	2015-01-20	Composições e métodos adjuvantes de antígeno
DK2049559T3 (da)	2013-03-25	Forbedrede HPV vacciner
EP2211787A4 (en)	2010-12-29	MITRAL SPACEUR
DK2200646T3 (da)	2013-10-21	RNA-Vacciner
DE602005027262D1 (de)	2011-05-12	Haendetrockner
EP2362781A4 (en)	2012-12-05	AZELLULAR PERTUSSIS COMBINATION VACCINE
NO20065944L (no)	2008-06-23	Umbilikal
DK2210105T3 (da)	2013-11-04	Mycobakterium-antigener
EP2245546A4 (en)	2015-02-18	ASYNCHRONOUS REPLICATION
BRPI0810865A2 (pt)	2017-05-09	antígenos de tripanossoma, composições vacinais, e métodos relacionados
BRPI0918583A2 (pt)	2015-12-01	válvula de expansão com equalização de força
PL2007419T3 (pl)	2012-09-28	Szczepionka przeciwko mykoplazmie i PRRSV
BRPI0816066A2 (pt)	2017-05-02	método de prevenção de nefrocalcinose
DK1985317T3 (da)	2013-08-26	Spacer-polymethylmethacrylat-knoglecement
PL2134743T3 (pl)	2013-01-31	Ulepszone szczepionki przeciw Bordetella pertussis oparte na mutantach glikozylo-transferazy LPS
EP2231969A4 (en)	2012-01-25	SHOCK ABSORBER
BRPI0821923A2 (pt)	2015-06-16	Ferramenta mecânica
EP1981964A4 (en)	2010-01-13	MYCOBACTERIAL SECA2 MUTANTS
ES1066600Y (es)	2008-05-16	Seguidor solar mecanico
EP1970074A4 (en)	2009-03-04	IMMUNE ADJUVANT
FI20075179A0 (fi)	2007-03-15	Kielisoitin
BRPI0815846A2 (pt)	2017-05-30	método para reforçar a imunogenicidade de uma vacina em um indivíduo.